NYSEMKT: RHERegional Health Properties Inc Stock
$3.26+0.14 (+4.49%)
Updated Jun 6, 2023
RHE Price
$3.26
Fair Value Price
N/A
Market Cap
$6.14M
52 Week Low
$2.13
52 Week High
$7.00
P/E
-0.39x
P/B
3.4x
P/S
0.19x
PEG
N/A
Dividend Yield
N/A
Revenue
$33.18M
Earnings
-$5.93M
Gross Margin
36%
Operating Margin
-10.17%
Profit Margin
-45%
Debt to Equity
35.54
Operating Cash Flow
$580k
Beta
0.97
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RHE Overview
Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed healthcare real estate investment company that invests primarily in real estate purposed for long-term and senior living. The company's facilities offer a range of health care and related services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of April 2, 2020, it owned, leased, or managed 24 facilities for third parties comprising 2,517 operational beds/units in Alabama, Georgia, North Carolina, Ohio, and South Carolina. The company was founded in 1988 and is headquartered in Suwanee, Georgia.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RHE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RHE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RHE is good value based on its book value relative to its share price (3.4x), compared to the US Medical Care Facilities industry average (4.61x)
P/B vs Industry Valuation
RHE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more RHE due diligence checks available for Premium users.
Be the first to know about important RHE news, forecast changes, insider trades & much more!
RHE News
Valuation
RHE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.39x
Industry
9.04x
Market
53.54x
RHE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.4x
Industry
4.61x
RHE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RHE's financial health
Profit margin
Revenue
$3.9M
Net Income
-$2.0M
Profit Margin
-108.6%
RHE's Earnings (EBIT) of -$3.38M... subscribe to Premium to read more.
Interest Coverage Financials
RHE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$66.0M
Liabilities
$64.1M
Debt to equity
35.54
RHE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
RHE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.6M
Investing
-$2.0k
Financing
-$685.0k
RHE's operating cash flow ($580.00k)... subscribe to Premium to read more.
Debt Coverage Financials
RHE vs Medical Care Facility Stocks
Regional Health Properties Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.